Filter membrane stent and vascular intervention device
By using a filter membrane stent with a one-way filter membrane and villus structure in vascular interventional surgery, the problems of blood reflux and blocking components are solved during vascular interventional surgery, and effective sealing and safe treatment of aneurysms are achieved. Effect.
Patent Information
- Application Number
- CN202323560082.9
- Authority / Receiving Office
- CN · China
- Patent Type
- Utility models(China)
- Current Assignee / Owner
- Filing Date
- 2023-12-26
- Publication Date
- 2024-11-29
- Estimated Expiration
- 2033-12-26
AI Technical Summary
Existing vascular interventional surgery has tiny gaps in the treatment of aneurysms that cause blood flow back, aneurysm regeneration and blocking components to be disengaged, increasing the complexity and risk of treatment.
A filter membrane stent including a stent body and a unidirectional filter membrane is designed. Multiple pores are formed on the stent body. The filter membrane is attached to the hemangioma opening. The filter membrane is made of a degradable material, and a villus structure is provided at both ends of the stent. To increase friction, the delivery mechanism and the sealing component are used for vascular intervention.
Effectively blocking hemangioma, preventing blood reflux and blocking components from being disengaged, improving the persistence and safety of treatment, and is suitable for hemangiomas of different sizes.
Smart Images

Figure CN222075367U_ABST
Abstract
Description
Technical Field
[0001] The utility model relates to the technical field of medical equipment, in particular to a filter membrane support and a vascular intervention device. Background Art
[0002] The most traditional treatment for intracranial aneurysms is open surgery, which is the most invasive and involves craniotomy. During the operation, a retractor is placed on the brain to gently open the channel between the brain and the skull. Once the aneurysm is visible, an aneurysm clip is placed across the neck of the aneurysm to clamp it closed. Open surgery is invasive and risky. Compared with vascular interventional surgery, it has higher technical requirements and a significantly higher mortality rate. At the same time, patients also need a longer recovery time.
[0003] Another less invasive treatment option is vascular intervention. In the early 1990s, the treatment of intracranial aneurysms was revolutionized by the introduction of embolic coils, and in 2001, a study compared the clinical outcomes of open surgery with those of embolic coils. After using embolic coil technology, the risk of death or serious events was significantly reduced by 22.6% after one year of follow-up. Since 2001, the use of embolic coils has grown rapidly and has been established as the preferred option for treating most aneurysms. Embolic coils are delivered through vascular intervention, so there is no need to open the skull. Physicians use embolic coils to fill the space in the aneurysm and replace the blood inside it.
[0004] However, the use of embolic coils alone also has its limitations. For example, it is actually impossible to use embolic coils to completely fill the space in the aneurysm because there will always be tiny gaps between the curls of the embolic coils, and blood will still flow into the aneurysm. Studies have also found that the embolic coils are further squeezed and compacted by the blood flow, which will lead to the regrowth of the aneurysm, requiring additional medical treatment. In addition, when embolic coils are used in aneurysms with wide necks, the embolic coils may also fall out and fall into the surrounding blood vessels, causing thromboembolic events. Utility Model Content
[0005] The purpose of the utility model is to provide a membrane filter stent and a vascular intervention device, which at least solves one of the technical problems existing in the prior art of treating aneurysms / vascular aneurysms by vascular intervention surgery.
[0006] In order to achieve the above-mentioned purpose, the utility model provides a filter membrane stent, including a stent body and a blood filter membrane, wherein a plurality of pores are formed on the stent wall of the stent body, the blood filter membrane is attached to the stent wall and at least covers the opening of the hemangioma, and the blood filter membrane is a unidirectional filter membrane.
[0007] Optionally, the blood filter membrane includes a plurality of filter holes, and the pore size of the filter hole on a side close to the blood vessel is smaller than the pore size of the filter hole on a side close to the hemangioma.
[0008] Optionally, the blood filter membrane is fixed to the support wall by heat shrinkage or sutures.
[0009] Optionally, the blood filter membrane is made of a biodegradable polymer material.
[0010] Optionally, both ends of the support body are provided with fluff structures.
[0011] Optionally, the fluff structure is made of degradable material.
[0012] Optionally, the bracket body is made of memory alloy.
[0013] Based on this, the utility model also provides a vascular intervention device, including a conveying mechanism and the filter membrane support as described above, wherein the conveying mechanism is used to convey the filter membrane support.
[0014] Optionally, the delivery mechanism includes a catheter, an introduction sheath and a delivery guidewire, the introduction sheath is arranged at the distal end of the catheter, the filter membrane support can be expanded and contracted within the catheter, and the delivery guidewire is used to drive the filter membrane support to move relative to the catheter.
[0015] Optionally, the vascular intervention device further includes a blocking component, and the blocking component is placed in the hemangioma.
[0016] The membrane support and vascular intervention device provided by the utility model have at least one of the following beneficial effects:
[0017] 1) By attaching a one-way filter membrane capable of at least covering the opening of the hemangioma to the stent body, not only can the blood in the hemangioma flow back into the blood vessel through the blood filter membrane, but also blood can be prevented from entering the hemangioma from the blood vessel, thereby draining the blood from the hemangioma;
[0018] 2) The filter membrane stent can be used alone when the hemangioma is small, and can be used together with a spring coil or other blocking component when the hemangioma is large, which can not only effectively block the hemangioma, but also prevent the blocking component from falling out of the opening of the hemangioma, thus achieving a good treatment effect;
[0019] 3) By providing villus structures at both ends of the stent body, the friction of the filter membrane stent in the blood vessel can be increased to prevent the filter membrane stent from sliding, thereby achieving continuous and effective occlusion of the hemangioma. BRIEF DESCRIPTION OF THE DRAWINGS
[0020] Those skilled in the art should understand that the drawings provided are for a better understanding of the present invention and do not constitute any limitation on the scope of the present invention.
[0021] Figure 1 A schematic diagram of the structure of the membrane support after expansion provided by one embodiment of the utility model;
[0022] Figure 2 A schematic diagram of a filter membrane support provided by an embodiment of the utility model when used alone;
[0023] Figure 3 A schematic diagram of the filter membrane support and the blocking component provided in one embodiment of the utility model when used in conjunction with each other;
[0024] Figure 4 An external top view of a blood filter membrane provided by an embodiment of the utility model;
[0025] Figure 5 This is a diagram of the internal structure of a blood filter membrane provided in one embodiment of the utility model.
[0026] in:
[0027] 10-stent body; 20-blood filter membrane; 21-filter hole; 30-hemangioma; 40-blood vessel; 50-villous structure; 60-occluding component. DETAILED DESCRIPTION
[0028] In order to make the purpose, advantages and features of the utility model clearer, the utility model is further described in detail in combination with the accompanying drawings and specific embodiments. It should be noted that the accompanying drawings are in a very simplified form and use non-precise proportions. They are only used to conveniently and clearly assist in explaining the purpose of the embodiments of the utility model, and are not used to limit the limiting conditions for the implementation of the utility model. Therefore, they have no technical substantive significance. Any structural modification, change in proportional relationship or adjustment of size should still fall within the scope of the technical content disclosed by the utility model without affecting the effects and purposes that can be achieved by the utility model.
[0029] It should also be understood that, unless otherwise specified or indicated, the terms "first", "second", "third", etc. in the specification are only used to distinguish between the various components, elements, steps, etc. in the specification, rather than to represent the logical relationship or sequential relationship between the various components, elements, steps, etc. Moreover, the terms "comprise", "include", or any other variants thereof are intended to cover non-exclusive inclusion, so that a process, method, article, or device including a series of elements includes not only those elements, but also other elements not explicitly listed, or also includes elements inherent to such process, method, article, or device. In the absence of further restrictions, an element defined by the sentence "comprises a ..." does not exclude the presence of other identical elements in the process, method, article, or device including the element.
[0030] Please refer to Figure 1-Figure 3 This embodiment provides a filter membrane stent, including a stent body 10 and a blood filter membrane 20, wherein a plurality of pores are formed on the stent wall of the stent body 10, the blood filter membrane 20 is attached to the stent wall and at least covers the opening of the hemangioma 30, and the blood filter membrane 20 is a unidirectional filter membrane.
[0031] By attaching a one-way filter membrane that can at least cover the opening of the hemangioma 30 to the stent body 10, not only can the blood in the hemangioma 30 flow back into the blood vessel 40 through the blood filter membrane 20, but also can prevent blood from entering the hemangioma 30 from the blood vessel 40, thereby draining the blood from the hemangioma 30. In addition, the filter membrane stent can be used alone when the hemangioma 30 is small, and can also be used together with a plugging component such as a spring coil when the hemangioma 30 is large, which can not only effectively plug the hemangioma 30, but also prevent the plugging component from falling out of the opening of the hemangioma 30, achieving a good treatment effect.
[0032] In this embodiment, please combine Figure 4 and Figure 5 The blood filter membrane 20 includes a plurality of filter holes 21, and the pore size of the filter hole 21 on the side close to the blood vessel 40 is smaller than the pore size of the filter hole 21 on the side close to the hemangioma 30. This design allows the blood in the hemangioma 30 to flow back into the blood vessel 40 through the blood filter membrane 20, while also preventing blood from entering the hemangioma 30 from the blood vessel 40.
[0033] It should be understood that the present invention does not impose any restrictions on the size of the blood filter membrane 20, as long as it can at least cover the opening of the hemangioma 30. Of course, the size of the blood filter membrane 20 cannot be too large. Since the filter membrane stent is usually expandable and contracted in the catheter, the size of the blood filter membrane 20 also needs to take into account the expansion of the stent body 10. In addition, the present invention does not impose any restrictions on the number, size, and distribution of the filter holes 21 on the blood filter membrane 20.
[0034] Preferably, the blood filter membrane 20 is fixed to the support wall by heat shrinkage or sutures.
[0035] In this embodiment, the blood filter membrane 20 can be made of polyvinyl chloride (PVC), polyethylene terephthalate (PET), polytetrafluoroethylene (PTFE), degradable materials (PLA, PLCL), etc. Preferably, the blood filter membrane 20 is made of a polymer material of a degradable material, and the degradation cycle of the filter membrane can be adjusted by adjusting the molecular weight of the polymer material to adapt to different diseases.
[0036] In this embodiment, the stent body 10 can be made of a memory alloy, preferably a nickel-titanium alloy. The stent body 10 can be formed by laser cutting, chemical etching, wire weaving, etc., and the utility model does not limit this.
[0037] Preferably, both ends of the stent body 10 are provided with villus structures 50 , and the villus structures 50 are used to increase the friction of the filter membrane stent in the blood vessel 40 to prevent the filter membrane stent from sliding, so as to achieve continuous and effective occlusion of the hemangioma 30 .
[0038] In this embodiment, the villi structure 50 is made of a degradable material and can be fixed to both ends of the stent body 10 by a weaving process.
[0039] Based on this, an embodiment of the utility model further provides a vascular intervention device, including a conveying mechanism and the filter membrane stent as described above, wherein the conveying mechanism is used to convey the filter membrane stent to the target lesion location to achieve occlusion of the hemangioma 30.
[0040] The membrane stent provided in this embodiment is implanted in the same manner as a conventional stent, and can be implanted alone or after the occluding components such as spring coils are implanted. The release point of the membrane stent can be released electrically or mechanically, and the utility model does not limit this. Among them, the release point of the membrane stent is preferably released electrically.
[0041] Furthermore, the delivery mechanism includes a catheter, an introduction sheath and a delivery guide wire, the introduction sheath is arranged at the distal end of the catheter, the filter membrane support can be expanded and contracted in the catheter, and the delivery guide wire is used to drive the filter membrane support to move relative to the catheter. It should be understood that the delivery mechanism is a prior art, and the utility model will not elaborate on it.
[0042] In this embodiment, the catheter can be a single-lumen or multi-lumen tubular structure, and the utility model does not impose any restrictions on this. Preferably, the catheter is a single-lumen tubular structure. The tube wall of the catheter can be composed of a single layer of material or multiple layers of different materials. The material can be a polymer such as polytetrafluoroethylene (PTFE), polyether block polyamide (Pebax), nylon and the like, and the utility model does not impose any restrictions on this.
[0043] When the volume of the hemangioma 30 is small and the filter membrane stent is used alone, the catheter serves as an intravascular channel, and the filter membrane stent is delivered to the vicinity of the opening of the hemangioma 30 by pushing the delivery guidewire. The filter membrane stent maintains the same shape in the catheter as in the introduction sheath, and is in a contracted state. When the blood filter membrane 20 reaches the preset position, the position of the filter membrane stent is adjusted so that the blood filter membrane 20 is aligned with the opening of the hemangioma 30. After the filter membrane stent is released from the distal end of the catheter, the stent body 10 made of memory alloy restores its original shape and expands the blood filter membrane 20, thereby sealing the hemangioma 30. Subsequently, the delivery guidewire is separated from the filter membrane stent, and the effect of the filter membrane stent acting alone is as follows. Figure 2 shown.
[0044] When the volume of the hemangioma 30 is relatively large, the filter membrane support is used in conjunction with a plugging component 60 such as a spring coil, and the plugging component 60 can be first inserted into the hemangioma 30, and then the filter membrane support is implanted in accordance with the above-mentioned implantation method. The blood filter membrane 20 can prevent the plugging component 60 from falling out while sealing the hemangioma 30. The effect of the use of the filter membrane support and the plugging component 60 is as follows: Figure 3 shown.
[0045] In summary, the embodiment of the utility model provides a membrane filter stent and a vascular intervention device. By attaching a one-way filter membrane that can at least cover the opening of the hemangioma 30 to the stent body 10, not only can the blood in the hemangioma 30 flow back into the blood vessel 40 through the blood filter membrane 20, but also can prevent blood from entering the hemangioma 30 from the blood vessel 40, thereby draining the blood from the hemangioma 30. In addition, the membrane filter stent can be used alone when the hemangioma 30 is small in size, and can also be used in conjunction with a sealing component such as a spring coil when the hemangioma 30 is large in size, which can not only effectively seal the hemangioma 30, but also prevent the sealing component from falling out of the opening of the hemangioma 30, achieving a good therapeutic effect.
[0046] In addition, it should be recognized that although the present invention has been disclosed as a preferred embodiment, the above embodiment is not intended to limit the present invention. For any technician familiar with the art, without departing from the scope of the technical solution of the present invention, the above disclosed technical content can be used to make many possible changes and modifications to the technical solution of the present invention, or modified into equivalent embodiments of equivalent changes. Therefore, any simple modification, equivalent change and modification made to the above embodiment based on the technical essence of the present invention without departing from the content of the technical solution of the present invention still falls within the scope of protection of the technical solution of the present invention.
Claims
1. A membrane support, characterized in that: It comprises a stent body and a blood filter membrane. A plurality of pores are formed on the stent wall of the stent body. The blood filter membrane is attached to the stent wall and at least covers the opening of the hemangioma. The blood filter membrane is a unidirectional filter membrane.
2. The membrane support according to claim 1, characterized in that: The blood filter membrane comprises a plurality of filter holes, and the pore size of the filter hole on the side close to the blood vessel is smaller than the pore size of the filter hole on the side close to the hemangioma.
3. The membrane support according to claim 1, characterized in that: The blood filter membrane is fixed on the support wall by heat shrinkage or sutures.
4. The membrane support according to claim 3, characterized in that: The blood filter membrane is made of a degradable polymer material.
5. The membrane support according to claim 1, characterized in that: Both ends of the support body are provided with fluff structures.
6. The membrane support according to claim 5, characterized in that: The fluff structure is made of degradable materials.
7. The membrane support according to claim 1, characterized in that: The support body is made of memory alloy.
8. A vascular intervention device, characterized in that: It comprises a conveying mechanism and a filter membrane support according to any one of claims 1 to 7, wherein the conveying mechanism is used to convey the filter membrane support.
9. The vascular intervention device according to claim 8, characterized in that: The delivery mechanism includes a catheter, an introduction sheath and a delivery guidewire. The introduction sheath is arranged at the distal end of the catheter. The filter membrane support can be expanded and contracted in the catheter. The delivery guidewire is used to drive the filter membrane support to move relative to the catheter.
10. The vascular intervention device according to claim 8, characterized in that: The vascular intervention device further includes a blocking component, which is placed in the hemangioma.
